Psychiatry, narcology and medical psychology

 
 

International Cooperation

The Department of Psychiatry, narcology and medical psychology due to the goal of improving the quality of provided services, improving the knowledge of evidence-based data and current tendencies in the field of mental health, collaborates with:

  • Paris Psychoanalytical Society (PPS), France (From 1996, twice a year, The Society of Psychoanalytical Psychotherapy from Moldova organizes seminars of the Society, with the participation of M. Ody, psychiatrist, psychoanalyst, titular member of PPS, team chief of the Mental Health Center “A. Binet” from Paris, in which it is discussed different clinical cases, but also a vast theoretical material).
  • Clinical Psychiatric Hospital Socola, Iași, Romania (annualy the members of the department participate with scientific speeches at the symposions of the Socola days); the level of CPH Socola being the clinical base for the Medicine and Pharmacy University Grigore T. Popa from Iași
  • Medicine and Pharmacy University Tîrgu Mureș, Romania
  • Babeș-Bolyai University, Cluj-Napoca, Romania
  • Public Health Institute Novy Sad, Serbia
  • De Nova University, Lisabona, Portugal

Clinical studies with participation of members of the Department Psychiatry, Narcology and Medical Psychology:

  • Allopurinol for mania: A randomized trial administering Allopurinol vs. placebo as add-on to mood stabilizers and/or antipsychotics in patients in a bipolar manic episode. Sponsor – Stanley Foundation, USA
  • A randomized trial administering Minocycline, Acetylsalicylic acid or Pramipexole vs Placebo as add-on to antipsychotics in patients with schizophrenia or schizoaffecive disorder – phase III-B. Sponsor – Stanley Foundation, USA
  • Randomized, Double-blind, Placebo-controlled, Multi-center Trial to Assess the Safety and Efficacy of RP5063 in Subjects with an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder – phase II. Sponsor – Stanley Foundation, USA
  • A randomized trial administering Raloxifene vs. Placebo as add-on to antipsychotics in post menopausal patients with schizophrenia or schizoaffecive disorder – phase III-B. Sponsor – Reviva Pharmaceuticals, Inc. 5941 Optical Court, Suite 215, San Jose, CA 95138, United States.